Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Showing results (351-360 of 899) with videos related to

Pageof 90
Sort By:
Blood|December 12, 2001
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblingsF Weissinger, B M Sandmaier, D G Maloney, et al.
Annals of Hematology|April 1, 1996
Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiationR Huss, D S Hong, C Beckham, et al.
Bone Marrow Transplantation|August 26, 1998
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantationJ L Wagner, M E Flowers, G Longton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasiaR P Witherspoon, H J Deeg, B Storer, et al.
Transplantation Proceedings|February 1, 1995
Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligandD S Hong, R Huss, C Beckham, et al.
Bone Marrow Transplantation|March 1, 1996
Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancyW I Bensinger, C D Buckner, S Rowley, et al.
Transplantation|September 1, 1983
Human T lymphocyte phenotypes after bone marrow transplantation. T cells expressing Ia-like antigenJ A Hansen, K Atkinson, P J Martin, et al.
Transplantation|May 1, 1983
Analysis of alloreactive and cytotoxic canine lymphocytes and their precursors with murine monoclonal antibodiesC Urban, J C Wulff, H J Deeg, et al.
Experimental Hematology|August 1, 1994
'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complexR F Raff, B M Sandmaier, T Graham, et al.
Clinical Genetics|April 1, 1990
Batten's disease: failure of allogeneic bone marrow transplantation to arrest disease progression in a canine modelH J Deeg, H M Shulman, D Albrechtsen, et al.
Pageof 90

Showing results (351-360 of 899) with videos related to

Sort By:
Pageof 90
Blood|December 12, 2001
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblingsF Weissinger, B M Sandmaier, D G Maloney, et al.
Annals of Hematology|April 1, 1996
Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiationR Huss, D S Hong, C Beckham, et al.
Bone Marrow Transplantation|August 26, 1998
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantationJ L Wagner, M E Flowers, G Longton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasiaR P Witherspoon, H J Deeg, B Storer, et al.
Transplantation Proceedings|February 1, 1995
Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligandD S Hong, R Huss, C Beckham, et al.
Bone Marrow Transplantation|March 1, 1996
Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancyW I Bensinger, C D Buckner, S Rowley, et al.
Transplantation|September 1, 1983
Human T lymphocyte phenotypes after bone marrow transplantation. T cells expressing Ia-like antigenJ A Hansen, K Atkinson, P J Martin, et al.
Transplantation|May 1, 1983
Analysis of alloreactive and cytotoxic canine lymphocytes and their precursors with murine monoclonal antibodiesC Urban, J C Wulff, H J Deeg, et al.
Experimental Hematology|August 1, 1994
'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complexR F Raff, B M Sandmaier, T Graham, et al.
Clinical Genetics|April 1, 1990
Batten's disease: failure of allogeneic bone marrow transplantation to arrest disease progression in a canine modelH J Deeg, H M Shulman, D Albrechtsen, et al.
Pageof 90